Adient Medical

The forward strategic vision of PEDC, its incentives for life science companies and the community’s close proximity to the Texas Medical Center and major research universities led Adient Medical to build its footprint in Pearland alongside other high-profile life science firms.

Adient, which developed the first absorbable blood filter for preventing pulmonary embolism, was also drawn to Pearland’s affordable housing and skilled labor force. The company’s 2018 relocation and opening of its 1,900 square-foot office and research space in the Reflection Bay of Shadow Creek produced over $600,000 in capital investment for Pearland.